Newsroom

In the U.S. diagnostic contract manufacturing market, technologies like microfluidics and advanced biosensors are gaining traction by enabling miniaturization and precision engineering for next-generation point-of-care and molecular diagnostic devices.

The advanced wound care market is growing from $11.61 billion in 2025 to $12.43 billion in 2026 at a 7% CAGR, driven by rising chronic wound prevalence and growing demand for advanced healing solutions. This ties directly to Advantage Converting's wound care converting expertise.

The wearable medical devices market is expected to grow from $67.45 billion in 2026 to $523.58 billion by 2035, at a CAGR of 25.57%, driven by rising chronic disease incidence and new non-invasive device developments.